%A Luo Mengchao, Ding Chaofeng, Wu Jian, Zheng Shusen %T Treatment progress of intrahepatic cholangiocarcinoma %0 Journal Article %D 2016 %J Journal of International Oncology %R 10.3760/cma.j.issn.1673,422X.2016.01.017 %P 60-63 %V 43 %N 1 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_9872.shtml} %8 2016-01-08 %X Surgical resection is still the mainstay for treatment of intrahepatic cholangiocarcinoma (ICC). Gemcitabine and cisplatin is a systemic therapy practice standard for patients with nonresectable ICC. Neoadjuvant therapy with liver transplantation may be a new therapeutic option for patients with ICC. In addition, radiotherapy, hepatic intraarterial therapy, ablation therapy and molecular targeted therapy are important components of comprehensive therapy for ICC.